Multisystem inflammatory syndrome in children with COVID-19 in a multitransfused patient
Multi-system inflammatory syndrome in children associated with COVID19 (MIS-C) is a unique clinical syndrome characterised by fever, gastrointestinal symptoms, skin and oral rash and or neurological symptoms in the presence of raised acute phase reactants and coagulopathy. Ferritin is an acute phase...
Saved in:
Main Authors: | Swarnalata Das, Manas Behera Ranjan, Palash Das |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-01-01
|
Series: | Asian Journal of Transfusion Science |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/ajts.ajts_112_21 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extracorporeal membrane therapy in a case of ruptured abscess on the mitroaortic intervalvular fibrosa associated to multisystem inflammatory syndrome: a case report
by: Lina P. Montaña-Jimenez, et al.
Published: (2025-01-01) -
Similarities and Differences between Coronavirus Disease 2019-related Multisystem Inflammatory Syndrome in Children and Kawasaki Disease in Indian Patients
by: Utkarsh Singh, et al.
Published: (2024-05-01) -
Long-COVID symptoms after multisystem inflammatory syndrome in children during different pandemic waves
by: Katarzyna Ptak, et al.
Published: (2024-10-01) -
Editorial: Multisystem inflammatory syndrome observed post-COVID-19: the role of natural products, medicinal plants and nutrients and the use of prediction tools supporting traditional forms of diagnosis
by: Anthony Booker, et al.
Published: (2025-01-01) -
Multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19, clinical characteristics: A multi-center observational study from Jordan
by: Marwan Shalabi, et al.
Published: (2025-06-01)